A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity. [electronic resource]
- American journal of clinical oncology Aug 1990
- 285-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0277-3732
10.1097/00000421-199008000-00003 doi
Adult Aged Antineoplastic Agents--administration & dosage Carboplatin Carcinoma, Non-Small-Cell Lung--drug therapy Carcinoma, Small Cell--drug therapy Drug Evaluation Drug Screening Assays, Antitumor Female Humans In Vitro Techniques Lung Neoplasms--drug therapy Male Middle Aged Neoplasm Recurrence, Local Organoplatinum Compounds--administration & dosage Remission Induction Tumor Cells, Cultured